nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—JUN—artery—Behcet's disease	0.0476	0.0749	CbGeAlD
Irbesartan—JUN—endothelium—Behcet's disease	0.0402	0.0633	CbGeAlD
Irbesartan—JUN—blood vessel—Behcet's disease	0.0371	0.0584	CbGeAlD
Irbesartan—AGTR1—artery—Behcet's disease	0.0358	0.0564	CbGeAlD
Irbesartan—JUN—mouth—Behcet's disease	0.031	0.0488	CbGeAlD
Irbesartan—AGTR1—endothelium—Behcet's disease	0.0303	0.0477	CbGeAlD
Irbesartan—AGTR1—Allograft Rejection—MICA—Behcet's disease	0.0282	0.0774	CbGpPWpGaD
Irbesartan—AGTR1—blood vessel—Behcet's disease	0.0279	0.044	CbGeAlD
Irbesartan—JUN—brainstem—Behcet's disease	0.0203	0.0319	CbGeAlD
Irbesartan—JUN—eye—Behcet's disease	0.0197	0.0311	CbGeAlD
Irbesartan—JUN—retina—Behcet's disease	0.0195	0.0308	CbGeAlD
Irbesartan—JUN—skin of body—Behcet's disease	0.0172	0.027	CbGeAlD
Irbesartan—EDNRA—mammalian vulva—Behcet's disease	0.0172	0.027	CbGeAlD
Irbesartan—EDNRA—cardiac atrium—Behcet's disease	0.0164	0.0259	CbGeAlD
Irbesartan—PTGS1—artery—Behcet's disease	0.0158	0.0248	CbGeAlD
Irbesartan—JUN—mammalian vulva—Behcet's disease	0.0157	0.0246	CbGeAlD
Irbesartan—EDNRA—medulla oblongata—Behcet's disease	0.0155	0.0244	CbGeAlD
Irbesartan—EDNRA—Peptide GPCRs—CCR1—Behcet's disease	0.0151	0.0414	CbGpPWpGaD
Irbesartan—JUN—cardiac atrium—Behcet's disease	0.015	0.0236	CbGeAlD
Irbesartan—EDNRA—midbrain—Behcet's disease	0.0142	0.0223	CbGeAlD
Irbesartan—JUN—medulla oblongata—Behcet's disease	0.0141	0.0222	CbGeAlD
Irbesartan—PTGS1—endothelium—Behcet's disease	0.0133	0.021	CbGeAlD
Irbesartan—JUN—midbrain—Behcet's disease	0.0129	0.0203	CbGeAlD
Irbesartan—JUN—spinal cord—Behcet's disease	0.0126	0.0198	CbGeAlD
Irbesartan—JUN—IL12 signaling mediated by STAT4—STAT4—Behcet's disease	0.0125	0.0343	CbGpPWpGaD
Irbesartan—PTGS1—blood vessel—Behcet's disease	0.0123	0.0193	CbGeAlD
Irbesartan—AGTR1—Peptide GPCRs—CCR1—Behcet's disease	0.0118	0.0325	CbGpPWpGaD
Irbesartan—AGTR1—cardiac atrium—Behcet's disease	0.0113	0.0178	CbGeAlD
Irbesartan—AGTR1—ACE Inhibitor Pathway—NOS3—Behcet's disease	0.0109	0.0298	CbGpPWpGaD
Irbesartan—AGTR1—medulla oblongata—Behcet's disease	0.0106	0.0168	CbGeAlD
Irbesartan—JUN—nervous system—Behcet's disease	0.0106	0.0167	CbGeAlD
Irbesartan—JUN—central nervous system—Behcet's disease	0.0102	0.0161	CbGeAlD
Irbesartan—JUN—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.00923	0.0253	CbGpPWpGaD
Irbesartan—EDNRA—brain—Behcet's disease	0.00889	0.014	CbGeAlD
Irbesartan—EDNRA—Endothelin Pathways—NOS3—Behcet's disease	0.00815	0.0223	CbGpPWpGaD
Irbesartan—JUN—brain—Behcet's disease	0.00811	0.0128	CbGeAlD
Irbesartan—AGTR1—nervous system—Behcet's disease	0.00799	0.0126	CbGeAlD
Irbesartan—AGTR1—central nervous system—Behcet's disease	0.0077	0.0121	CbGeAlD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.00715	0.0196	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CCR1—Behcet's disease	0.0071	0.0195	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—STAT4—Behcet's disease	0.00665	0.0182	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—CTLA4—Behcet's disease	0.00664	0.0182	CbGpPWpGaD
Irbesartan—JUN—FOXA1 transcription factor network—APOB—Behcet's disease	0.00633	0.0174	CbGpPWpGaD
Irbesartan—AGTR1—brain—Behcet's disease	0.00611	0.00962	CbGeAlD
Irbesartan—PTGS1—skin of body—Behcet's disease	0.00568	0.00895	CbGeAlD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—ITGB2—Behcet's disease	0.00564	0.0155	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CCR1—Behcet's disease	0.00557	0.0153	CbGpPWpGaD
Irbesartan—EDNRA—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.00556	0.0152	CbGpPWpGaD
Irbesartan—CYP2D6—brainstem—Behcet's disease	0.00551	0.00868	CbGeAlD
Irbesartan—PTGS1—mammalian vulva—Behcet's disease	0.00518	0.00816	CbGeAlD
Irbesartan—AGTR1—Allograft Rejection—IL10—Behcet's disease	0.00516	0.0141	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—ITGB2—Behcet's disease	0.00503	0.0138	CbGpPWpGaD
Irbesartan—PTGS1—cardiac atrium—Behcet's disease	0.00496	0.00781	CbGeAlD
Irbesartan—AGTR1—Allograft Rejection—HLA-B—Behcet's disease	0.00491	0.0135	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.00476	0.0131	CbGpPWpGaD
Irbesartan—PTGS1—Overview of nanoparticle effects—CXCL8—Behcet's disease	0.0046	0.0126	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—Behcet's disease	0.00459	0.0126	CbGpPWpGaD
Irbesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR1—Behcet's disease	0.00436	0.012	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—Behcet's disease	0.00436	0.012	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—IL10—Behcet's disease	0.00425	0.0116	CbGpPWpGaD
Irbesartan—PTGS1—spinal cord—Behcet's disease	0.00417	0.00657	CbGeAlD
Irbesartan—JUN—RANKL/RANK Signaling Pathway—ICAM1—Behcet's disease	0.00398	0.0109	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—ITGB2—Behcet's disease	0.00396	0.0109	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—Behcet's disease	0.00387	0.0106	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—IL10—Behcet's disease	0.00378	0.0104	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR1—Behcet's disease	0.00374	0.0102	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCR1—Behcet's disease	0.00363	0.00994	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—ITGAL—Behcet's disease	0.00357	0.00979	CbGpPWpGaD
Irbesartan—PTGS1—nervous system—Behcet's disease	0.00351	0.00553	CbGeAlD
Irbesartan—PTGS1—central nervous system—Behcet's disease	0.00338	0.00533	CbGeAlD
Irbesartan—JUN—TGF-beta Receptor Signaling—SERPINE1—Behcet's disease	0.00338	0.00925	CbGpPWpGaD
Irbesartan—CYP2C8—brain—Behcet's disease	0.00331	0.00522	CbGeAlD
Irbesartan—PTGS1—Overview of nanoparticle effects—TNF—Behcet's disease	0.0032	0.00878	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—CAT—Behcet's disease	0.00316	0.00865	CbGpPWpGaD
Irbesartan—JUN—IL-3 Signaling Pathway—CXCL8—Behcet's disease	0.00309	0.00847	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.00304	0.00833	CbGpPWpGaD
Irbesartan—CYP3A4—nervous system—Behcet's disease	0.00294	0.00462	CbGeAlD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—ICAM1—Behcet's disease	0.00289	0.00793	CbGpPWpGaD
Irbesartan—CYP2D6—nervous system—Behcet's disease	0.00289	0.00455	CbGeAlD
Irbesartan—JUN—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.00288	0.00788	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCR1—Behcet's disease	0.00285	0.0078	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—Behcet's disease	0.00283	0.00776	CbGpPWpGaD
Irbesartan—CYP3A4—central nervous system—Behcet's disease	0.00283	0.00445	CbGeAlD
Irbesartan—AGTR1—Allograft Rejection—CXCL8—Behcet's disease	0.00282	0.00773	CbGpPWpGaD
Irbesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.0028	0.00768	CbGpPWpGaD
Irbesartan—CYP2D6—central nervous system—Behcet's disease	0.00278	0.00438	CbGeAlD
Irbesartan—JUN—AGE/RAGE pathway—NOS3—Behcet's disease	0.00275	0.00752	CbGpPWpGaD
Irbesartan—PTGS1—brain—Behcet's disease	0.00269	0.00423	CbGeAlD
Irbesartan—JUN—ATF-2 transcription factor network—CXCL8—Behcet's disease	0.00266	0.0073	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—CAT—Behcet's disease	0.00262	0.00717	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—APOB—Behcet's disease	0.00254	0.00696	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—CXCL8—Behcet's disease	0.0025	0.00684	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MEFV—Behcet's disease	0.00247	0.00677	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear SMAD2/3 signaling—SERPINE1—Behcet's disease	0.00244	0.00669	CbGpPWpGaD
Irbesartan—JUN—FAS pathway and Stress induction of HSP regulation—TNF—Behcet's disease	0.00243	0.00667	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—TNF—Behcet's disease	0.00243	0.00667	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—CXCL8—Behcet's disease	0.00232	0.00637	CbGpPWpGaD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.00226	0.0062	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL10—Behcet's disease	0.00224	0.00613	CbGpPWpGaD
Irbesartan—CYP2D6—brain—Behcet's disease	0.00221	0.00348	CbGeAlD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	0.00212	0.0058	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Behcet's disease	0.00209	0.00572	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CCR1—Behcet's disease	0.00205	0.00562	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—CXCL8—Behcet's disease	0.00205	0.00561	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—APOA1—Behcet's disease	0.00201	0.0055	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—TNF—Behcet's disease	0.00199	0.00545	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—SERPINE1—Behcet's disease	0.00198	0.00543	CbGpPWpGaD
Irbesartan—CYP1A2—Tryptophan metabolism—CAT—Behcet's disease	0.00197	0.00541	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—TNF—Behcet's disease	0.00197	0.00538	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.00191	0.00523	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCR1—Behcet's disease	0.00186	0.0051	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.00178	0.00488	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.00172	0.00471	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—TNF—Behcet's disease	0.0017	0.00464	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—CXCL8—Behcet's disease	0.00168	0.0046	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—Behcet's disease	0.00168	0.0046	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—ITGB2—Behcet's disease	0.00163	0.00446	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCR1—Behcet's disease	0.00161	0.00441	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.00159	0.00437	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—SERPINE1—Behcet's disease	0.00158	0.00432	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CAT—Behcet's disease	0.00156	0.00426	CbGpPWpGaD
Irbesartan—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.00152	0.00417	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CCR1—Behcet's disease	0.00146	0.004	CbGpPWpGaD
Irbesartan—JUN—Immune System—MEFV—Behcet's disease	0.00144	0.00394	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—Behcet's disease	0.0014	0.00383	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TNF—Behcet's disease	0.0014	0.00383	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—NOS3—Behcet's disease	0.00139	0.0038	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.00134	0.00368	CbGpPWpGaD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.00134	0.00367	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—TNF—Behcet's disease	0.0013	0.00356	CbGpPWpGaD
Irbesartan—JUN—Immune System—ERAP1—Behcet's disease	0.00128	0.00351	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—CXCL8—Behcet's disease	0.00122	0.00335	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	0.0012	0.00328	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.0012	0.00328	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—SERPINE1—Behcet's disease	0.00118	0.00323	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR1—Behcet's disease	0.0011	0.00301	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CXCL8—Behcet's disease	0.00106	0.00291	CbGpPWpGaD
Irbesartan—JUN—Immune System—ITGB2—Behcet's disease	0.000948	0.0026	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—Behcet's disease	0.00094	0.00258	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000938	0.00257	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	0.000934	0.00256	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CXCL8—Behcet's disease	0.000911	0.0025	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR1—Behcet's disease	0.000863	0.00236	CbGpPWpGaD
Irbesartan—JUN—Immune System—ITGAL—Behcet's disease	0.000856	0.00234	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—Behcet's disease	0.000852	0.00233	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CXCL8—Behcet's disease	0.000803	0.0022	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—Behcet's disease	0.000803	0.0022	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HLA-B—Behcet's disease	0.000748	0.00205	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000725	0.00199	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCL8—Behcet's disease	0.000715	0.00196	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.00071	0.00194	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.00071	0.00194	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR1—Behcet's disease	0.000645	0.00177	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTLA4—Behcet's disease	0.000589	0.00161	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.00057	0.00156	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOB—Behcet's disease	0.000519	0.00142	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL8—Behcet's disease	0.000515	0.00141	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL8—Behcet's disease	0.000467	0.00128	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CAT—Behcet's disease	0.000465	0.00127	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000451	0.00124	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOB—Behcet's disease	0.000451	0.00124	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-B—Behcet's disease	0.000435	0.00119	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOA1—Behcet's disease	0.000411	0.00113	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOB—Behcet's disease	0.000407	0.00112	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000404	0.00111	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000368	0.00101	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL8—Behcet's disease	0.000367	0.001	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOA1—Behcet's disease	0.000357	0.000978	CbGpPWpGaD
Irbesartan—JUN—Immune System—ICAM1—Behcet's disease	0.000354	0.000969	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SERPINE1—Behcet's disease	0.000326	0.000893	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOA1—Behcet's disease	0.000322	0.000883	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOS3—Behcet's disease	0.000311	0.000853	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOB—Behcet's disease	0.000304	0.000834	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.0003	0.000822	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000292	0.000799	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL8—Behcet's disease	0.000276	0.000756	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—Behcet's disease	0.00027	0.000741	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAT—Behcet's disease	0.000262	0.000717	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000256	0.000702	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SERPINE1—Behcet's disease	0.000256	0.000701	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOB—Behcet's disease	0.000254	0.000696	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—Behcet's disease	0.000244	0.000669	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOA1—Behcet's disease	0.000241	0.00066	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000237	0.00065	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—Behcet's disease	0.000217	0.000594	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000203	0.000556	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOA1—Behcet's disease	0.000201	0.000551	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SERPINE1—Behcet's disease	0.000191	0.000524	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—Behcet's disease	0.000182	0.0005	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAT—Behcet's disease	0.000169	0.000463	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOB—Behcet's disease	0.000164	0.00045	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—Behcet's disease	0.000162	0.000443	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—Behcet's disease	0.000152	0.000417	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAT—Behcet's disease	0.000139	0.00038	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAT—Behcet's disease	0.000138	0.000377	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOB—Behcet's disease	0.000135	0.000369	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOB—Behcet's disease	0.000134	0.000366	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOA1—Behcet's disease	0.00013	0.000356	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAT—Behcet's disease	0.000118	0.000322	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOB—Behcet's disease	0.000114	0.000313	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA1—Behcet's disease	0.000107	0.000292	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA1—Behcet's disease	0.000106	0.00029	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—Behcet's disease	9.84e-05	0.00027	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAT—Behcet's disease	9.07e-05	0.000249	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA1—Behcet's disease	9.03e-05	0.000247	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOB—Behcet's disease	8.81e-05	0.000241	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—Behcet's disease	8.08e-05	0.000221	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—Behcet's disease	8.01e-05	0.000219	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA1—Behcet's disease	6.97e-05	0.000191	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—Behcet's disease	6.84e-05	0.000187	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—Behcet's disease	5.28e-05	0.000145	CbGpPWpGaD
